Back to results
US 8,299,044 B2Granted
Apoptosis inducer for cancer cell
AssigneeGenecare Research Institute Co., Ltd.
InventorsMotoki Takagi, Akira Shimamoto, Yasuhiro Furuichi, Ayumi Sato
Life of this patent
Estimating the term…
Abstract
The present invention revealed that by suppressing the expression of the WRN gene, the BLM gene, or the RecQ1 gene, which belong to the RecQ helicase family, apoptosis is induced in various cancer cells and their proliferation is suppressed. Compounds that suppress the expression of RecQ helicase family genes or the functions of RecQ helicase proteins are thought to have the activity of inducing apoptosis.
Claims3
A method for inducing apoptosis of cancer cells comprising the steps of:
- (a) administering a double-stranded RNA that has RNAi activity toward a RecQ1 gene and suppresses the expression of the RecQ1 gene into a subject;
- and
- (b) assessing the viability of the subject;
- wherein the double stranded RNA induces apoptosis in cancer cells but does not induce apoptosis in normal cells, and comprises a sense RNA comprising a sequence homologous to an arbitrary 20 to 30 consecutive nucleotides from the mRNA of the RecQ1 gene, and an antisense RNA, comprising the sequence complementary to the sense RNA;
- and
- wherein either strand of the double-stranded RNA with RNAi activity comprises the nucleotide sequence of any one of SEQ ID NOs:
- 1, 31 to 34, and 43 to 52.
4 more elements
Dependencies are inferred from the claim text.